(Bloomberg)– Johnson & &Johnson, among the many final United States enterprise with main credit score report scores, goes to risk of shedding its AAA high quality from S&P Global Ratings after the producer of medicines and medical instruments acknowledged it was acquiring Intra-Cellular Therapies Inc
Most Read from Bloomberg
S&P acknowledged on Tuesday that it’s inspecting whether or not it wants to scale back the agency’s credit score report scores, partially for the reason that $14.6 billion procurement would definitely enhance J&J’s debt. J&J will most certainly make much more debt-funded purchases sooner or later, in response to S&P.
A downgrade for J&J would definitely leaveMicrosoft Corp as the one United States agency ranked AAA. Seven corporations internationally– consisting of banks– have an AAA rating from S&P, in response to an agent with the scores agency. That’s under 16 a years again and 88 in 2005. The current itemizing consists of Temasek Holdings, Public Sector Pension Investment Board and Airservices Australia.
Ratings declines can enhance a enterprise’s loaning costs, though relating to enterprise within the highest attainable scores charges, any type of distinction is perhaps little or no.
On Monday, J&J acknowledged that it’s moneying the Intra-Cellular Therapies acquisition with cash and monetary debt. It anticipates to close on the cut price this 12 months.
Separately, Moody’s Ratings on Tuesday verified J&J’s current AAA rating. Johnson & & Johnson has “cash-on-hand of over $20 billion as well as very strong annual free cash-flow generation,” in response to the bond-grading firm.
–With assist from Ethan M Steinberg.
(Updates to incorporate context on number of enterprise ranked AAA by S&P within the third paragraph.)
Most Read from Bloomberg Businessweek
© 2025 Bloomberg L.P.
